Enhertu is a combination of a chemotherapy drug and targeted therapy. But it’s commonly called an antibody-drug conjugate, which means it contains a monoclonal antibody linked to a drug.

A conjugate vaccine is a substance that is composed of a polysaccharide antigen fused (conjugated) to a carrier molecule. This enhances the stability and the effectiveness of the vaccine.

Journal of Nuclear Medicine February 2025, jnumed.124.268857; DOI: https://doi.org/10.2967/jnumed.124.268857 ...

Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL) in humans, and it is a highly heterogeneous malignancy with a 40% to 50% risk of relapsed or ...

Dioscorea nipponica rhizoma (DNR) is commonly used for the cure of hyperthyroidism resulting from Graves’ disease (GD) or thyroid nodules. However, its therapeutic mechanism remains unclear. This ...

Limited or Ligand Pharmaceuticals Incorporated is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Treatment Options for Bladder Cancer: Bringing Life to Years of Sparse Options - Guru Sonpavde ...

Navai discussed vicinium, which is an antibody drug conjugate-like recombinant fusion protein of humanized anti-EpCAM antibody ... is approved by the US FDA for patients with BCG-unresponsive ...

S. et al. Comparison of lobectomy vs total thyroidectomy for intermediate-risk papillary thyroid carcinoma with lymph node metastasis. JAMA Surg. 158, 73–79 (2023). 【关于投稿】 转化 ...